» Articles » PMID: 30097900

The Secretory Phenotype of Senescent Astrocytes Isolated from Wistar Newborn Rats Changes with Anti-inflammatory Drugs, but Does Not Have a Short-term Effect on Neuronal Mitochondrial Potential

Overview
Journal Biogerontology
Specialty Geriatrics
Date 2018 Aug 12
PMID 30097900
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

In the central nervous system (CNS), senescent astrocytes have been associated with neurodegeneration. Senescent cells secrete a complex mixture of pro-inflammatory factors, which are collectively called Senescence Associated Secretory Phenotype (SASP). The SASP components can vary depending on the cell type, senescence inducer and time. The SASP has been mainly studied in fibroblasts and epithelial cells, but little is known in the context of the CNS. Here, the SASP profile in senescent astrocytes isolated from Wistar newborn rats induced to senescence by oxidative stress or by proteasome inhibition was analyzed. Senescent astrocytes secreted predominantly chemokines and IL-1α, but no IL-6. The effect of the anti-inflammatory drugs, sulforaphane (SFN) and dehydroepiandrosterone (DHEA), on the SASP profile was evaluated. Our results showed that SFN and DHEA decreased IL-1α secretion while increasing IL-10, thus modifying the SASP to a less anti-inflammatory profile. Primary neurons were subjected to the conditioned media obtained from drug-treated senescent astrocytes, and their mitochondrial membrane potential was evaluated.

Citing Articles

Inflammaging and Brain Aging.

Jurcau M, Jurcau A, Cristian A, Hogea V, Diaconu R, Nunkoo V Int J Mol Sci. 2024; 25(19).

PMID: 39408862 PMC: 11476611. DOI: 10.3390/ijms251910535.


IL-10 deficiency aggravates cell senescence and accelerates BLM-induced pulmonary fibrosis in aged mice via PTEN/AKT/ERK pathway.

Li Y, Yin H, Yuan H, Wang E, Wang C, Li H BMC Pulm Med. 2024; 24(1):443.

PMID: 39261827 PMC: 11389321. DOI: 10.1186/s12890-024-03260-x.


Anti-Inflammatory Therapeutic Mechanisms of Isothiocyanates: Insights from Sulforaphane.

Habtemariam S Biomedicines. 2024; 12(6).

PMID: 38927376 PMC: 11200786. DOI: 10.3390/biomedicines12061169.


Glioprotective Effects of Sulforaphane in Hypothalamus: Focus on Aging Brain.

Santos C, Weber F, Bello-Klein A, Bobermin L, Quincozes-Santos A Neurochem Res. 2024; 49(9):2505-2518.

PMID: 38886329 DOI: 10.1007/s11064-024-04196-8.


Senescence and SASP Are Potential Therapeutic Targets for Ischemic Stroke.

Ouvrier B, Ismael S, Bix G Pharmaceuticals (Basel). 2024; 17(3).

PMID: 38543098 PMC: 10973994. DOI: 10.3390/ph17030312.